Catalyst Wire Dossier Catalyst Wire Dossier

venetoclax and azacitidine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for venetoclax and azacitidine, covering 2026-06-11 to 2026-06-11. Get the full timeline:

Most recent: Clinical Trial Results: Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia [Phase 2]

See pricing